Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptus PharmaBOM:544529 -1.98%18 Net Current Asset Value is ₹8.77 as of Mar. 2026, which is 100% below its 10-year median of 15.92. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 77 Medical Distribution companies, Aptus Pharma ranks worse than 96.1% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Aptus Pharma's net current asset value per share for the quarter that ended in Mar. 2026 was ₹8.77.
The historical rank and industry rank for Aptus Pharma's Net Current Asset Value or its related term are showing as below:
BOM:544529'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 15.92 Med: 15.92 Max: 31.9
Current: 31.27
During the past 4 years, the highest Price-to-Net-Current-Asset-Value Ratio of Aptus Pharma was 31.90. The lowest was 15.92. And the median was 15.92.
BOM:544529's Price-to-Net-Current-Asset-Value is ranked worse than 96.1% of 77
companies
in the Medical Distribution industry
Industry Median: 3.09
vs BOM:544529: 31.27
Aptus Pharma (BOM:544529) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Aptus Pharma Net Current Asset Value Related Terms
Aptus Pharma Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Aptus Pharma's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544529 vs MCK, COR, CAH: Net Current Asset Value Comparison
For the Medical Distribution subindustry, Aptus Pharma's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptus Pharma Price-to-Net-Current-Asset-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Aptus Pharma's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Aptus Pharma's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₹8.77 mean?
Aptus Pharma (BOM:544529) has a Net Current Asset Value of ₹8.77 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Aptus Pharma and its competitors. This is 45% below median its historical median of 15.92. Over the past decade, Aptus Pharma's Net Current Asset Value has ranged from 15.92 to 31.90. According to the industry distribution chart, Aptus Pharma ranks #74 out of 77 companies in the Medical Distribution industry, placing it in the top 96.1%.
Is Aptus Pharma's Net Current Asset Value too high?
Aptus Pharma's current Net Current Asset Value of ₹8.77 is 45% below median its 10-year median of 15.92. Over the past 10 years, this metric has ranged from a low of 15.92 to a high of 31.90. Based on the distribution chart, Aptus Pharma ranks #74 out of 77 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's Net Current Asset Value compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Aptus Pharma ranks #74 out of 77 companies for Net Current Asset Value. This places Aptus Pharma in the lower half of its industry. The industry median Net Current Asset Value is 3.09. Historically, Aptus Pharma's own Net Current Asset Value has ranged from 15.92 to 31.90 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Distribution company?
The median Net Current Asset Value among Medical Distribution companies is 3.09, based on 77 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Aptus Pharma and its competitors. For the Medical Distribution industry, the median Net Current Asset Value is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptus Pharma's current Net Current Asset Value is ₹8.77, which is 45% below median its own 10-year median of 15.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current Net Current Asset Value of ₹8.77. The current Net Current Asset Value is ₹8.77, which is 45% below median its 10-year median of 15.92. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current Net Current Asset Value is ₹8.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score
Get the complete analysis for BOM:544529
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544529 has been successfully added to your 
